22.01.2018 16:13:26

DGAP-Stimmrechtsanteile: Epigenomics AG

DGAP-PVR: Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

DGAP Voting Rights Announcement: Epigenomics AG
Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

22.01.2018 / 16:13
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Notification of Major Holdings

1. Details of issuer
Epigenomics AG
Geneststraße 5
10829 Berlin
Germany

2. Reason for notification
X Acquisition/disposal of shares with voting rights
  Acquisition/disposal of instruments
  Change of breakdown of voting rights
  Other reason:

3. Details of person subject to the notification obligation
Name: City and country of registered office:
Global Bio and Information Technologies Partners GP Ltd. George Town, Grand Cayman
Cayman Islands

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
Globetrotter (BVI) Holdings, Ltd.

5. Date on which threshold was crossed or reached:
29 Dec 2017

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)		 % of voting rights through instruments
(total of 7.b.1 + 7.b.2)		 total of both in %
(7.a. + 7.b.)		 total number of voting rights of issuer
Resulting situation 4.67 % % 4.67 % 24014360
Previous notification 9.19 % % 9.19 % /

7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 33, 34 WpHG)
ISIN absolute in %
  direct
(Sec. 33 WpHG)		 indirect
(Sec. 34 WpHG)		 direct
(Sec. 33 WpHG)		 indirect
(Sec. 34 WpHG)
DE000A11QW50 1120685 % 4.67 %
Total 1120685 4.67 %

b.1. Instruments according to Sec. 38 para. 1 No. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
%
    Total %

b.2. Instruments according to Sec. 38 para. 1 No. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
%
      Total %

8. Information in relation to the person subject to the notification obligation
  Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more)
Global Bio Information Technologies Partners GP Ltd. % % %
Global Bio and Information Technologies Partners L.P. % % %
Team Curis Group % % %
Biochain (BVI) Holdings, Ltd. % % %
BioChain Institute, Inc. % % %
Globetrotter (BVI) Holdings, Ltd. 4.67 % % %

9. In case of proxy voting according to Sec. 34 para. 3 WpHG

Date of general meeting:
Holding position after general meeting: % (equals voting rights)

10. Other explanatory remarks:
In the course of the separation of Team Curis Group, shares formerly held by Globetrotter (BVI) Holdings, Ltd. and Bio-Epi (BVI) Holdings, Ltd. have been disposed of.  


22.01.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
Language: English
Company: Epigenomics AG
Geneststraße 5
10829 Berlin
Germany
Internet: www.epigenomics.com

 
End of News DGAP News Service

647463  22.01.2018 

fncls.ssp?fn=show_t_gif&application_id=647463&application_name=news&site_id=smarthouse

Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!

Nachrichten zu Epigenomics AGmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Epigenomics AGmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Newssuche

GO

Börse aktuell - Live Ticker

Notenbanken im Fokus: Dow schlussendlich schwächer -- ATX und schließen DAX im Minus -- Asiens Börsen letztlich in Rot
Der heimische und der deutsche Aktienmarkt präsentierten sich mit Verlusten zum Wochenstart. Die US-Börsen notierten uneins. Die asiatischen Börsen zeigten sich am Montag schwächer.

Nachrichten

Aktien ATX  DAX  EuroStoxx 50  Dow Jones  NASDAQ 100  Nikkei 225  S&P 500 

Kontakt  - Impressum - Werbung

Sitemap  - Datenschutz  - Disclaimer  - AGB  - Privatsphäre-Einstellungen